Grant: Catalyst Grant: Post Market Drug Safety and Effectiveness
University of Alberta
$100,000.00
The Changing Face of Children's Pain Management: Using Genomics to Inform Safe and Effective Prescription Practices.
EF 2011-12
Résumé
In Canada, countless children experience injuries and pain every day. This pain is often diffucult for the child (and their family) to deal with. Children with pain are commonly told to take painkillers at home. These painkillers are variable in how well they work. They can also cause pretty bad side effects, that may cause a family to stop using them, even though the child is still in pain. Under-treated pain can cause both immediate and long-term ill effects for a child.
The effects of medicine (both good and bad) might be due, in part, to each person's DNA. DNA is the building block of our bodies, and is what make each person a little bit different from the next. Some people's DNA allows them to have more pain relief than others, even when two people are given the same medicine. These DNA differences can also cause one person to have more bad side effects with a medicine, than another person. This study will try to figure out how DNA changes can affect a child's ability to have lesser side effects and feel better with oxycodone, a pain medicine used for children. We will then use this information to help figure out the best medicines to prescribe for each unique child.
Programme
Catalyst Grant: Post Market Drug Safety and Effectiveness
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
243567
Name
Ali Samina
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Projecttitle
The Changing Face of Children's Pain Management: Using Genomics to Inform Safe and Effective Prescription Practices.
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Keyworddelim
Child Health; Drug Effectiveness; Drug Safety; Pain; Pharmacogenomics
Abstract
In Canada, countless children experience injuries and pain every day. This pain is often diffucult for the child (and their family) to deal with. Children with pain are commonly told to take painkillers at home. These painkillers are variable in how well they work. They can also cause pretty bad side effects, that may cause a family to stop using them, even though the child is still in pain. Under-treated pain can cause both immediate and long-term ill effects for a child.
The effects of medicine (both good and bad) might be due, in part, to each person's DNA. DNA is the building block of our bodies, and is what make each person a little bit different from the next. Some people's DNA allows them to have more pain relief than others, even when two people are given the same medicine. These DNA differences can also cause one person to have more bad side effects with a medicine, than another person. This study will try to figure out how DNA changes can affect a child's ability to have lesser side effects and feel better with oxycodone, a pain medicine used for children. We will then use this information to help figure out the best medicines to prescribe for each unique child.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ali, Samina
Approvedterm
1 an 0 mois
Cihrcontribution2
DSEN~ $30,000~ $0~Inst of Musculoskel Hlth &Arth~ $40,000~ $0~Institute of Genetics~ $30,000~ $0~